Therapeutic effects of intra-arterial administration of glial progenitor cells-conditioned medium in acute experimental ishemic stroke in rats
- Authors: Cherkashova E.A1, Salikhova D.I2,3, Namestnikova D.D4, Leonov G.E2, Gubskiy I.L1, Solovieva A.A1, Akopyan G.B1, Kurilo V.V4, Nikitina M.P3, Fatkhudinov T.K.3,5, Chekhonin V.P4, Gubskiy L.V1,4, Yarygin K.N6,7, Bukharova T.B2, Goldshtein D.V2,5
-
Affiliations:
- Federal Center for brain and neurotechnology of the Federal medical and biological agency
- Research Centre for Medical Genetics
- Research Institute of Human Morphology
- N.I. Pirogov Russian National Research Medical University
- Peoples' Friendship University of Russia
- V.N. Orehovich Institute of Biomedical Chemistry
- Russian Medical Academy of Continuous Professional Education
- Issue: Vol 15, No 3 (2020)
- Pages: 80-84
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/122003
- DOI: https://doi.org/10.23868/202011013
- ID: 122003
Cite item
Abstract
Full Text

About the authors
E. A Cherkashova
Federal Center for brain and neurotechnology of the Federal medical and biological agency
D. I Salikhova
Research Centre for Medical Genetics; Research Institute of Human Morphology
D. D Namestnikova
N.I. Pirogov Russian National Research Medical University
G. E Leonov
Research Centre for Medical Genetics
I. L Gubskiy
Federal Center for brain and neurotechnology of the Federal medical and biological agency
A. A Solovieva
Federal Center for brain and neurotechnology of the Federal medical and biological agency
G. B Akopyan
Federal Center for brain and neurotechnology of the Federal medical and biological agency
V. V Kurilo
N.I. Pirogov Russian National Research Medical University
M. P Nikitina
Research Institute of Human Morphology
T. Kh Fatkhudinov
Research Institute of Human Morphology; Peoples' Friendship University of Russia
V. P Chekhonin
N.I. Pirogov Russian National Research Medical University
L. V Gubskiy
Federal Center for brain and neurotechnology of the Federal medical and biological agency; N.I. Pirogov Russian National Research Medical University
K. N Yarygin
V.N. Orehovich Institute of Biomedical Chemistry; Russian Medical Academy of Continuous Professional Education
T. B Bukharova
Research Centre for Medical Genetics
D. V Goldshtein
Research Centre for Medical Genetics; Peoples' Friendship University of Russia
References
- Powers W.J., Rabinstein A.A., Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50(12): 344-8.
- Donkor E.S. Stroke in the Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke research and treatment 2018; 2018: 1-10.
- Marei H.E., Hasan A., Rizzi R. et al. Potential of Stem Cell-Based Therapy for Ischemic Stroke. Front. Neurol. 2018; 9: 34.
- Xu W., Zheng J., Gao L. et al. Neuroprotective Effects of Stem Cells in Ischemic Stroke. Stem cells international 2017; 2017: 1-7.
- Abeliovich A., Doege C.A. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease. Neuron 2009; 61(3): 337-9.
- Okano H., Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Molecular brain 2014; 7(1): 22-5
- Poulos J. The limited application of stem cells in medicine: a review. Stem cell research & therapy 2018; 9(1): 1-6.
- Jha M.K., Seo M., Kim J.H. et al. The secretome signature of reactive glial cells and its pathological implications. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 2013; 1834(11): 2418-28.
- Ruiz C., Casarejos M.J., Gomez A. et al. Protection by glia-conditioned medium in a cell model of Huntington disease. PLoS Сurrents 2012; 4: 20-8.
- Салихова Д.И., Леонов Г.Е., Бухарова Т.Б. и др. Сравнительный анализ влияния кондиционированных сред, полученных от нейрональных и глиальных предшественников, на мозжечковые нейроны при глутаматной эксайтотоксичности. Гены и Клетки 2019; 14(4): 46-53.
- Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
- Koizumi J. Experimental studies of ischemic brain edema. 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese Journal of Stroke 1986; 8: 1-8.
- Longa E.Z., Weinstein P.R., Carlson S. et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20(1): 84-91.
- Gubskiy I.L., Namestnikova D.D., Cherkashova E.A. et al. MRI Guiding of the middle cerebral artery occlusion in rats aimed to improve stroke modeling. Translational stroke research 2018; 9(4): 417-25.
- Schaar K.L., Brenneman M.M., Savitz S.I. et al. Functional assessments in the rodent stroke model. Experimental & translational stroke medicine 2010; 2(1): 13.
- Tuttolomondo A., Raimondo D., Sciacca R. et al. Inflammatory cytokines in acute ischemic stroke. Current pharmaceutical design 2008; 14(33): 3574-89.
- Janssen K., Bahnassawy L., Kiefer C. et al. Generating human iPSC-derived astrocytes with chemically defined medium for in vitro disease modeling. Methods Mol. Biol. 2019; 1994: 31-9.
- Yang H., Wang C., Chen H. et al. Neural stem cell-conditioned medium ameliorated cerebral ischemia-reperfusion injury in rats. Stem cells international 2018; 2018: 1-7.
- Tsai M.J., Tsai S.K., Hu B.R. et al. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats. Journal of biomedical science 2014; 21(1): 1-12.
- Watanabe T., Nagai A., Sheikh A.M. et al. Human neural stem cell line provides neuroprotection and improves neurological performance by early intervention of neuroinflammatory system. Brain research 2016; 1631: 194-203.
